I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: ALLERGY THERA. ORD 0.1P AGY Announcements

ALLERGY THERA. ORD 0.1P (AGY) Announcements

Date Time Source Announcement
16 Jan 2020 12:25 pm
RNS
Trading Update & Notice of Results - Replacement
  8:00 am
EQS
Allergy Therapeutics (AGY): Sales growth well a...
  7:00 am
RNS
Half Year Trading Update & Notice of Results
02 Dec 2019 9:57 am
RNS
Holdings in Company
29 Nov 2019 10:34 am
RNS
Holdings in Company
26 Nov 2019 7:00 am
RNS
Update to Grass MATA MPL Ph III clinical programme
25 Nov 2019 12:13 pm
RNS
Result of Annual General Meeting
22 Oct 2019 9:23 am
RNS
Annual Report and Accounts
26 Sep 2019 7:30 am
EQS
Allergy Therapeutics (AGY): Continuing to gain ...
25 Sep 2019 7:00 am
RNS
Preliminary Results
11 Jul 2019 7:00 am
RNS
Trading update
01 Jul 2019 7:20 am
EQS
Allergy Therapeutics (AGY): Successful legal ou...
  7:15 am
EQS
Oxford BioMedica (OXB): Eying up long-term value
27 Jun 2019 7:00 am
RNS
Successful Litigation Settlement
  7:00 am
RNS
Trading Statement
19 Jun 2019 7:00 am
RNS
Board Change
11 Jun 2019 7:00 am
RNS
Holdings in Company
21 May 2019 8:30 am
EQS
Titon Holdings Plc (TON): You need hands
  7:15 am
EQS
Allergy Therapeutics (AGY): House dust mite vac...
20 May 2019 7:00 am
RNS
Positive top line phase I results for Acarovac MPL
14 May 2019 7:00 am
RNS
Holdings in Company
13 May 2019 6:14 pm
RNS
Holding(s) in Company
  4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
07 May 2019 7:00 am
RNS
Research Published on Adjuvant Systems
25 Apr 2019 7:00 am
RNS
Regulatory and Trading Update
18 Mar 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:30 am
EQS
Allergy Therapeutics (AGY): Take an objective view
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Top Line Phase III results from B301 trial
06 Mar 2019 12:10 pm
EQS
Allergy Therapeutics (AGY): Strong operating pe...
  7:00 am
RNS
Interim Results
17 Jan 2019 9:56 am
EQS
Allergy Therapeutics (AGY): Trading update: gai...
16 Jan 2019 7:00 am
RNS
Trading Update & Notice of Results
29 Nov 2018 5:59 pm
RNS
Holdings in Company
27 Nov 2018 1:12 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Trading Update
12 Nov 2018 12:00 pm
RNS
Presentation at Jefferies Healthcare Conference
08 Nov 2018 7:00 am
RNS
Directorate Change
07 Nov 2018 6:06 pm
RNS
Holdings in Company
02 Nov 2018 7:00 am
RNS
Grant of Awards under Long Term Incentive Plan
24 Oct 2018 1:25 pm
RNS
Holdings in Company
  7:00 am
RNS
Director/PDMR Shareholding
23 Oct 2018 5:29 pm
RNS
Annual Report and Accounts
  3:28 pm
RNS
Holdings in Company
27 Sep 2018 7:15 am
EQS
Allergy Therapeutics (AGY): 2018 full-year resu...
26 Sep 2018 7:00 am
RNS
Preliminary Results
08 Aug 2018 7:00 am
RNS
Notice of Results
27 Jul 2018 5:26 pm
RNS
Holding(s) in Company
26 Jul 2018 12:02 pm
RNS
Holding(s) in Company
19 Jul 2018 10:19 am
RNS
Results of Placing and Subscription
  7:00 am
RNS
Proposed placing & subscription to raise �10.6m
16 Jul 2018 8:53 am
RNS
BLOCK LISTING SIX MONTHLY RETURN
13 Jul 2018 9:40 am
EQS
Allergy Therapeutics (AGY): Steady performance ...
12 Jul 2018 7:00 am
RNS
Trading Update
25 Jun 2018 7:52 am
RNS
Positive data of Pollinex Quattro Grass vaccine

Top announcements

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close